| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
2'-Amino-2'-deoxy-5-methylcytidine manufacturers
|
| | 2'-Amino-2'-deoxy-5-methylcytidine Basic information |
| Product Name: | 2'-Amino-2'-deoxy-5-methylcytidine | | Synonyms: | 2'-Amino-2'-deoxy-5-methylcytidine;Cytidine, 2'-amino-2'-deoxy-5-methyl- (9CI);2’-Amino-2’-deoxy-5-methylcytidine;4-amino-1-((2R,3R,4S,5R)-3-amino-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one | | CAS: | 869729-45-3 | | MF: | C10H16N4O4 | | MW: | 256.26 | | EINECS: | | | Product Categories: | | | Mol File: | 869729-45-3.mol |  |
| | 2'-Amino-2'-deoxy-5-methylcytidine Chemical Properties |
| Boiling point | 525.5±60.0 °C(Predicted) | | density | 1.78±0.1 g/cm3(Predicted) | | pka | 13.66±0.70(Predicted) |
| | 2'-Amino-2'-deoxy-5-methylcytidine Usage And Synthesis |
| Uses | 2’-Amino-2’-deoxy-5-methylcytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2'-Amino-2'-deoxy-5-methylcytidine Preparation Products And Raw materials |
|